IP Library Granted Patent US 8,378,137
Granted Patent B2
US 8,378,137 · App. 13/208,176 · Granted Feb 19, 2013

Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,378,137
App. No.
13/208,176
Granted
Feb 19, 2013
Kind
B2
Abstract

Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

Claims (52)

1. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of formula (XI) or a salt thereof, comprising contacting a compound of Formula (I) or a salt thereof with gabapentin or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is methyl;

R 3 is hydrogen; and

R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl or substituted aryl ring.

2. The method of claim 1 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl ring.

3. The method of claim 2 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted cyclohexyl ring.

4. The method of claim 1 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted aryl ring.

5. The method of claim 4 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted phenyl ring.

6. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of Formula (XII) or a salt thereof, comprising contacting a compound of Formula (I) or a salt thereof with baclofen or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is isopropyl;

R 3 is hydrogen; and

R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl or substituted aryl ring.

7. The method of claim 6 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl ring.

8. The method of claim 7 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted cyclohexyl ring.

9. The method of claim 6 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted aryl ring.

10. The method of claim 9 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted phenyl ring.

11. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of Formula (XIII) or salt thereof comprising contacting a compound of Formula (I) or salt thereof with R-(−)-baclofen or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is isopropyl;

R 3 is hydrogen; and

R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl or substituted aryl ring.

12. The method of claim 11 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl ring.

13. The method of claim 12 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted cyclohexyl ring.

14. The method of claim 11 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted aryl ring.

15. The method of claim 14 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted phenyl ring.

16. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of the formula:

or salt thereof comprising contacting a compound of Formula (I) or salt thereof with tranexamic acid or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is methyl;

R 3 is hydrogen; and

R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl or substituted aryl ring.

17. The method of claim 16 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl ring.

18. The method of claim 17 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted cyclohexyl ring.

19. The method of claim 16 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted aryl ring.

20. The method of claim 19 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted phenyl ring.

21. A method of synthesizing a 1-(acyloxy)-alkyl carbamate compound of the formula:

or salt thereof comprising contacting a compound of Formula (I) or salt thereof with pregabalin or a salt thereof:

wherein:

R 1 is isopropyl;

R 2 is methyl;

R 3 is hydrogen; and

R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl or substituted aryl ring.

22. The method of claim 21 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted cycloalkyl ring.

23. The method of claim 22 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted cyclohexyl ring.

24. The method of claim 21 , wherein R 5 and R 6 together with the atoms to which they are attached form a substituted aryl ring.

25. The method of claim 24 , wherein R 5 and R 6 together with the atoms to which they are attached form a 1,2-disubstituted phenyl ring.

Assignments (8)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
SECURITY INTEREST Recorded Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2013
From: GALLOP, MARK A.; SCHEUERMAN, RANDALL A.; DAI, XUEDONG; RAILLARD, STEPHEN P.; MANTHATI, SURESH K.; YAO, FENMEI; LUDWIKOW, MARIA; PHAN, THU; PENG, GE; BHAT, SEEMA
To: XENOPORT, INC.
Reel/Frame 029621/0454 →